![Frank Manganella](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Manganella
Corporate Officer/Principal chez
NEXIEN BIOPHARMA, INC.
Profil
Frank Manganella is the founder and CEO of CH3 Partners LLC, which was founded in 2015.
He is also the founder of Ch3 Ventures.
Currently, he holds the position of Vice President-Corporate Development at Nexien BioPharma, Inc. since 2018 and the position of Chief Financial Officer & Managing Partner at CRx Bio Holdings LLC since 2017.
In the past, he worked as Managing Director & Head-FICC Sales at Commerzbank AG from 2011 to 2014.
Mr. Manganella received an MBA from Durham University Business School in 2013.
Postes actifs de Frank Manganella
| Sociétés | Poste | Début |
|---|---|---|
| NEXIEN BIOPHARMA, INC. | Corporate Officer/Principal | 30/10/2018 |
CH3 Partners LLC | Directeur Général | 01/10/2015 |
CRx Bio Holdings LLC
 CRx Bio Holdings LLC Pharmaceuticals: OtherHealth Technology Engages in research and development of cannabinoid-based pharmaceuticals | Directeur Financier/CFO | 01/11/2017 |
Ch3 Ventures | Fondateur | - |
Anciens postes connus de Frank Manganella
| Sociétés | Poste | Fin |
|---|---|---|
| COMMERZBANK AG | Corporate Officer/Principal | 01/06/2014 |
Formation de Frank Manganella
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Commerzbank AG
 Commerzbank AG Regional BanksFinance Provides commercial banking services | Finance |
Durham University Business School
 Durham University Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nexien BioPharma, Inc.
 Nexien BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of cannabinoid-based pharmaceutical products for neuromuscular disorders | Health Technology |
CRx Bio Holdings LLC
CRx Bio Holdings LLC Pharmaceuticals: OtherHealth Technology Engages in research and development of cannabinoid-based pharmaceuticals | Health Technology |
CH3 Partners LLC | |
Ch3 Ventures |
